A Phase 3 Study to Evaluate the 1-Year Efficacy and Safety of Udenafil 75 mg Once Daily in Patients With Erectile Dysfunction

Moon Ki Hak; Kim Sae Woong; Moon Du Geon; Kim Je Jong; Park Nam Cheol; Lee Sung Won; Paick Jae-Seung; Ahn Tai Young; Chung Woo Sik; Min Kwon Sik; Park Jong Kwan; Yang Dae Yul; Shin Hong Seok; Park Kwangsung

首页> 外文期刊>The journal of sexual medicine >A Phase 3 Study to Evaluate the 1-Year Efficacy and Safety of Udenafil 75 mg Once Daily in Patients With Erectile Dysfunction

【24h】

A Phase 3 Study to Evaluate the 1-Year Efficacy and Safety of Udenafil 75 mg Once Daily in Patients With Erectile Dysfunction

机译：评估勃起功能障碍患者每天1次使用Udenafil 75 mg的1年疗效和安全性的3期研究

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Introduction: Once-daily administration of phosphodiesterase type 5 inhibitors has been shown to correct erectile dysfunction (ED).

机译：简介：每天一次给予5型磷酸二酯酶抑制剂可纠正勃起功能障碍（ED）。

著录项

来源
《The journal of sexual medicine》 |2016年第8期|共7页
作者
Moon Ki Hak; Kim Sae Woong; Moon Du Geon; Kim Je Jong; Park Nam Cheol; Lee Sung Won; Paick Jae-Seung; Ahn Tai Young; Chung Woo Sik; Min Kwon Sik; Park Jong Kwan; Yang Dae Yul; Shin Hong Seok; Park Kwangsung;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类性卫生;
关键词
Erectile Dysfunction; Phosphodiesterase Type 5 Inhibitors; Udenafil; Long Term;

机译：勃起功能障碍;磷酸二酯酶5型抑制剂;Udenafil;长期;

相似文献

外文文献
中文文献
专利

1. A Phase 3 Study to Evaluate the 1-Year Efficacy and Safety of Udenafil 75 mg Once Daily in Patients With Erectile Dysfunction [J] . Moon Ki Hak, Kim Sae Woong, Moon Du Geon, The journal of sexual medicine . 2016,第8期

机译：评估勃起功能障碍患者每天1次使用Udenafil 75 mg的1年疗效和安全性的3期研究
2. Comparison of the efficacy and safety of once-daily dosing and on-demand use of udenafil for type 2 diabetic patients with erectile dysfunction [J] . Soon Hyun Park, Sung Woo Park, Bong Yun Cha, Asian journal of andrology . 2015,第1期

机译：每日一次剂量和按需使用乌地那非治疗2型糖尿病勃起功能障碍患者的疗效和安全性比较
3. Re: Comparison of the Efficacy and Safety of Once-Daily Dosing and On-Demand Use of Udenafil for Type 2 Diabetic Patients with Erectile Dysfunction [J] . Seftel Allen D. The Journal of Urology . 2015,第4期

机译：RE：对勃起功能障碍2型糖尿病患者的次数给药和按需使用的效果和安全性的比较
4. Comparative study between PSSR and PSEP in evaluating erectile dysfunction caused by pelvic fracture associated with posterior urethral disruption [C] . Wang F.X., Zhang L.L., Shen Y., International Academy of Legal Medicine., Congress . 2013

机译：PSSR与PSEP评估骨盆断裂引起的腹部骨折破裂引起的勃起功能障碍的比较研究
5. Safety and Efficacy of the Immunomodulatory Drug (IMiD) Lenalidomide in Patients with Lymphoma: Development of RU051417I - Phase I/II Open-Label Study of R-ICE (Rituximab-Ifosfamide-Carboplatin-Etoposide) with Lenalidomide [R2-ICE] in Patients with First-Relapse/Primary Refractory Diffuse Large B-Cell Lymphoma (DLBCL). [D] . Kasi, Pashtoon Murtaza. 2018

机译：免疫调节药物来那度胺在淋巴瘤患者中的安全性和有效性：RU051417I-R-ICE（利妥昔单抗-异环磷酰胺-卡铂-依托泊苷）与来那度胺[R2-ICE]的I / II期开放标签研究的进展初次复发/原发性难治性弥漫性大B细胞淋巴瘤（DLBCL）。
6. Commentary on – Comparison of the efficacy and safety of once-daily dosing and on-demand use of udenafil for type 2 diabetic patients with erectile dysfunction [O] . De-Hong Cao, Liang-Ren Liu, Qiang Wei 2015

机译：关于每日两次剂量和按需使用乌地那非治疗2型糖尿病勃起功能障碍患者的疗效和安全性比较的评论
7. Comparison of the efficacy and safety of once-daily dosing and on-demand use of udenafil for type 2 diabetic patients with erectile dysfunction [O] . Soon Hyun Park, Sung Woo Park, Bong Yun Cha, 2015

机译：比较每日一次给药和按需使用乌地那非治疗2型糖尿病勃起功能障碍患者的疗效和安全性

A Phase 3 Study to Evaluate the 1-Year Efficacy and Safety of Udenafil 75 mg Once Daily in Patients With Erectile Dysfunction

摘要

著录项

相似文献

相关主题

期刊订阅